The present invention relates to a novel use of a panduratin derivative or a Boesenbergia pandurata extract. More specifically, the invention relates to a composition for preventing and treating/relieving a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes, containing a panduratin derivative represented by Chemical Formula 1, 2 or 3 or a Boesenbergia pandurata extract as an active ingredient, a method for treating a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes, by administering an effective amount of the panduratin derivative or the Boesenbergia pandurata extract to a subject in need thereof, and a use of the panduratin derivative or the Boesenbergia pandurata extract to prepare a reagent for preventing and treating/relieving a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes. As can be seen foregoing, the present invention provides a novel use of a panduratin derivative or a Boesenbergia pandurata extract. A panduratin derivative or a Boesenbergia pandurata extract of the present invention shows excellent effects on a metabolic disease such as obesity, hyperlipidemia, hypercholesterolemia and diabetes by decreasing highly related causes of metabolic diseases such as on weight, body fat and lipid-content. Since a composition of the present invention is originated from natural materials, it can be used without side effect and provides novel method for preventing and treating/relieving a metabolic disease through body weight loss and body fat loss and the like.본 발명은 판두라틴 유도체 또는 보에센베르기아 판두라타(Boesenbergia pandurata) 추출물의 신규한 용도에 관한 것으로, 보다 상세하게는 화학식 1 내지 3으로 표시되는 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물을 유효성분으로 포함하는 비만, 고지혈증, 고콜레스테롤증 및 당뇨병으로 이루어진 군에서 선택된 대사성 질환 예방 및 치료/개선용 조성물에 관한 것이다. 본 발명은 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 새로운 용도를 제공한다. 본 발명의 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물은 체중, 체지방,
